Latest Strategic Reviews News

Page 2 of 60
Piche Resources has identified more than 19 new epithermal structures at its Cerro Chacón project in Argentina, including a 2km vein and rock-chip results of up to 10.41 g/t gold and 553.42 g/t silver. The next test is whether those surface signals translate into a coherent mineralised system at depth.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Kingston Resources has reported high-grade polymetallic drilling results across Mineral Hill while advancing a 25,000-metre FY27 campaign and planning resource and reserve updates. The company ended September with A$14.54 million in cash and no debt, but the mine remains on care and maintenance and its strategic review has no guaranteed outcome.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Cynata Therapeutics will raise approximately $912,962 after shareholders subscribed for just 25.8% of its fully underwritten entitlement offer. Caravel Securities will fund the remaining shortfall, leaving the biotech reliant on the underwriter to complete the raise.
Ada Torres
Ada Torres
30 Oct 2026
Encounter Resources has reported thick, high-grade niobium intersections across its Aileron project, while a new copper corridor at Yeneena adds another potential growth avenue. The September quarter also brought a strategic review of the copper portfolio, leadership changes and $20.35 million in cash.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Eclipse Metals has begun a 17-hole, 2,355-metre drilling campaign at its 208Mt Grønnedal rare earths project, while reporting $2.987 million in cash and an estimated 2.8 quarters of funding. The quarter also delivered a maiden Ivigtût critical-minerals resource and restored full ownership of the Liverpool uranium portfolio.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.
Ada Torres
Ada Torres
29 Oct 2026
Integral Diagnostics has opened FY27 below expectations, with radiologist and sonographer shortages limiting revenue growth and pushing labour costs ahead of sales. The company expects FY27 revenue growth of 4% to 6% and a full-year operating EBITDA margin of 19.5% to 20.5%, with improvement weighted to the second half.
Ada Torres
Ada Torres
29 Oct 2026
Future Metals has advanced its Panton PGM project with an updated 4.24Moz PtEq resource, a potentially lower-capital processing route and two competing development pathways. A completed A$3.6 million placement funds the next phase, while the Savannah option still depends on commercial agreement and further technical work.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Heavy Rare Earths has identified 10 interpreted high-grade heavy rare earth oxide domains within its Subron project, while expanding the project footprint and advancing drilling across South Australia. The company also completed the components of a capital raising worth up to $2.028 million, although several key milestones remain dependent on approvals, access and further technical work.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Magontec’s nine-month revenue rose 28.9% to A$59.4 million as stronger electronic anode sales and a recovery in Metals lifted gross profit to A$12.8 million. The turnaround is generating cash before working-capital movements, but Chinese demand, European automotive weakness and near-term debt maturities remain live risks.
Victor Sage
Victor Sage
29 Oct 2026
Challenger Gold has reset its Hualilan strategy around a larger integrated mine after ending the Casposo toll-milling campaign, while new debt funding extends the project’s runway. The company is targeting early 2029 production, but only A$25.8 million was held in cash at quarter-end and part of the proposed financing remains conditional.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Everest Metals has built Mt Dimer’s ROM stockpile to more than 142,000 tonnes while advancing toll processing, a Revere development study and a strategic review of its Mt Edon rubidium project. The company ended September with A$4.1 million in cash, leaving execution and funding as the next tests.
Maxwell Dee
Maxwell Dee
29 Oct 2026

Browse the archive

Full archive